137 related articles for article (PubMed ID: 21975730)
41. Dermatitis following systemic prednisolone: patch testing with prednisolone eye drops.
Harris A; McFadden JP
Australas J Dermatol; 2000 May; 41(2):124-5. PubMed ID: 10812710
[TBL] [Abstract][Full Text] [Related]
42. Antiinflammatory therapies for cystic fibrosis: past, present, and future.
Prescott WA; Johnson CE
Pharmacotherapy; 2005 Apr; 25(4):555-73. PubMed ID: 15977917
[TBL] [Abstract][Full Text] [Related]
43. Inhaled corticosteroids in treatment of cystic fibrosis.
Erdem E; Ersu R
Antiinflamm Antiallergy Agents Med Chem; 2012; 11(3):206-9. PubMed ID: 23061610
[TBL] [Abstract][Full Text] [Related]
44. Intravenous immunoglobulin for cystic fibrosis lung disease: a case series of 16 children.
Balfour-Lynn IM; Mohan U; Bush A; Rosenthal M
Arch Dis Child; 2004 Apr; 89(4):315-9. PubMed ID: 15033837
[TBL] [Abstract][Full Text] [Related]
45. Inflammation and cystic fibrosis pulmonary disease.
Kennedy MJ
Pharmacotherapy; 2001 May; 21(5):593-603. PubMed ID: 11349748
[TBL] [Abstract][Full Text] [Related]
46. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis.
Ziesche R; Hofbauer E; Wittmann K; Petkov V; Block LH
N Engl J Med; 1999 Oct; 341(17):1264-9. PubMed ID: 10528036
[TBL] [Abstract][Full Text] [Related]
47. Interleukin-1 alpha, soluble interleukin-2 receptor, and IgG concentrations in cystic fibrosis treated with prednisolone.
Greally P; Hussain MJ; Vergani D; Price JF
Arch Dis Child; 1994 Jul; 71(1):35-9. PubMed ID: 8067791
[TBL] [Abstract][Full Text] [Related]
48. The role of inhaled corticosteroids in the management of cystic fibrosis.
Ross KR; Chmiel JF; Konstan MW
Paediatr Drugs; 2009; 11(2):101-13. PubMed ID: 19301932
[TBL] [Abstract][Full Text] [Related]
49. Oral corticosteroids and bone pain after pamidronate in adults with cystic fibrosis.
Haworth CS; Selby PL; Webb AK; Adams JE; Freemont TJ
Lancet; 1999 May; 353(9167):1886. PubMed ID: 10359445
[No Abstract] [Full Text] [Related]
50. Clinicopathologic, hemodynamic, and echocardiographic effects of short-term oral administration of anti-inflammatory doses of prednisolone to systemically normal cats.
Khelik IA; Berger DJ; Mochel JP; Seo YJ; Palerme JS; Ware WA; Ward JL
Am J Vet Res; 2019 Aug; 80(8):743-755. PubMed ID: 31339769
[TBL] [Abstract][Full Text] [Related]
51. Targeting airway inflammation in cystic fibrosis in children: past, present, and future.
Pressler T
Paediatr Drugs; 2011 Jun; 13(3):141-7. PubMed ID: 21500868
[TBL] [Abstract][Full Text] [Related]
52. Resolved: Low-dose glucocorticoids are neither safe nor effective for the long-term treatment of rheumatoid arthritis.
Saag KG
Arthritis Rheum; 2001 Oct; 45(5):468-71. PubMed ID: 11642647
[No Abstract] [Full Text] [Related]
53. Therapies aimed at airway inflammation in cystic fibrosis.
Konstan MW
Clin Chest Med; 1998 Sep; 19(3):505-13, vi. PubMed ID: 9759552
[TBL] [Abstract][Full Text] [Related]
54. Efficacy of short-course oral prednisolone in polymorphic light eruption: a randomized controlled trial.
Patel DC; Bellaney GJ; Seed PT; McGregor JM; Hawk JL
Br J Dermatol; 2000 Oct; 143(4):828-31. PubMed ID: 11069465
[TBL] [Abstract][Full Text] [Related]
55. Mechanisms of airway inflammation in cystic fibrosis.
Döring G
Pediatr Allergy Immunol; 1996; 7(9 Suppl):63-6. PubMed ID: 9156732
[No Abstract] [Full Text] [Related]
56. Pharmacological approaches for the discovery and development of new anti-inflammatory agents for the treatment of cystic fibrosis.
Konstan MW; Davis PB
Adv Drug Deliv Rev; 2002 Dec; 54(11):1409-23. PubMed ID: 12458152
[TBL] [Abstract][Full Text] [Related]
57. Clinical profile of the functionally selective glucocorticoid receptor agonist BI 653048 in healthy male subjects.
Harcken C; Scholl P; Nabozny G; Thomson D; Bianchi D
Expert Opin Investig Drugs; 2019 May; 28(5):489-496. PubMed ID: 30908082
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of rescue oral glucocorticoid therapy during inpatient cystic fibrosis exacerbations.
Muirhead CA; Lanocha N; Markwardt S; MacDonald KD
Pediatr Pulmonol; 2021 May; 56(5):891-900. PubMed ID: 33289316
[TBL] [Abstract][Full Text] [Related]
59. [Hypertrophic myocardiopathy associated with oral corticosteroids in an infant with cutaneous hemangioma].
Aldecoa Bilbao V; Viaplana Bartolí G; Teodoro Marín S; Perich Durán RM
An Pediatr (Barc); 2008 Feb; 68(2):197-8. PubMed ID: 18341893
[No Abstract] [Full Text] [Related]
60. Hyaluronic acid for the treatment of airway diseases in children: Little evidence for few indications.
Di Cicco M; Peroni D; Sepich M; Tozzi MG; Comberiati P; Cutrera R
Pediatr Pulmonol; 2020 Aug; 55(8):2156-2169. PubMed ID: 32530559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
